Breakthrough Phase-III results for next-generation GLP-1 obesity drugs have injected fresh momentum into the MSCI World Health Care Index. Traders have dubbed this the MSCI healthcare GLP-1 rally. With the index up 9 percent in just eight trading sessions, investors…
While gene-therapy approvals advance, the MSCI World Health Care Index is rallying. Therefore, investors are reassessing healthcare index performance and long-term growth prospects in the sector. 1. Gene-Therapy Approvals Drive Sector Optimism First, breakthrough FDA and EMA approvals for next-generation…
A sector-specific benchmark that bundles large- and mid-cap health-care companies from 23 developed markets, thereby offering investors a single, globally diversified snapshot of everything from blockbuster drugmakers to cutting-edge medical-device suppliers. 1. Why the Index Matters First and foremost, health-care…